LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

LONGITUDINAL ANALYSES OF DIAGNOSTIC‐RELAPSE BIOPSIES OF DIFFUSE LARGE B CELL LYMPHOMA SUGGEST THAT RELAPSE IS MEDIATED BY DISTINCT MECHANISMS IN ABC AND GCB LYMPHOMA

Photo by jannerboy62 from unsplash

Janssen. Hodkinson, B: Employment Leadership Position: Janssen R&D. Schaffer, M: Employment Leadership Position: Janssen; Stock Ownership: Janssen. Sehn, L: Consultant Advisory Role: Celgene, AbbVie, Seattle Genetics, TG Therapeutics, Janssen, Amgen,… Click to show full abstract

Janssen. Hodkinson, B: Employment Leadership Position: Janssen R&D. Schaffer, M: Employment Leadership Position: Janssen; Stock Ownership: Janssen. Sehn, L: Consultant Advisory Role: Celgene, AbbVie, Seattle Genetics, TG Therapeutics, Janssen, Amgen, Roche/Genentech, Gilead Sciences, Lundbeck, Apobiologix, Karyopharm Therapeutics, Kite Pharma, Merck, Takeda Pharmaceuticals, TEVA Pharmaceuticals Industries, TG Therapeutics; Honoraria: Amgen, Apobiologix, AbbVie, Celgene, Gilead Sciences, Janssen-Ortho, Karyopharm Therapeutics, Kite Pharma, Lundbeck, Merck, Roche/Genentech, Seattle Genetics, Takeda Pharmaceuticals, TEVA Pharmaceuticals Industries, TG Therapeutics; Research Funding: Roche/Genentech (Inst). Johnson, P: Consultant Advisory Role: Janssen, Epizyme, Boehringer Ingelheim; Honoraria: Takeda Pharmaceuticals, Bristol-Myers Squibb, Novartis, Celgene, Kite Pharma, Genmab, Incyte, MorphoSys; Research Funding: Janssen, Epizyme; Other Remuneration: Combined use of Fc gamma RIIb (CD32b) and CD20-specific antibodies; WO patent, PCT/GB2011/051572; EU11760819.0. Zinzani, P: Honoraria: Servier, Bristol-Myers Squibb, Gilead, Jansen, Merck Sharp & Dohme, Celltrion, Celgene, Roche; Other Remuneration: Verastem, Servier, Bristol-Myers Squibb, Gilead, Janssen, Merck Sharp & Dohme, Celltrion, Celgene, Roche. Carey, J: Employment Leadership Position: Janssen Research and Development; Stock Ownership: Johnson & Johnson. Liu, G: Employment Leadership Position: Janssen. Loefgren, C: Employment Leadership Position: Janssen; Stock Ownership: Janssen. Shreeve, M: Employment Leadership Position: Janssen; Stock Ownership: Johnson & Johnson, Pfizer. Sun, S: Employment Leadership Position: Johnson & Johnson; Stock Ownership: Johnson & Johnson. Zhuang, S: Employment Leadership Position: Janssen Research & Development; Stock Ownership: Johnson & Johnson. Vermeulen, J: Employment Leadership Position: Janssen; Stock Ownership: Janssen. Staudt, L: Other Remuneration: Patents and patents pending regarding gene expression profiling in lymphoma that have been licensed by Nanostring and for which I receive royalties. Younes, A: Consultant Advisory Role: BMS, Incyte, Janssen, Genentech and Merck; Honoraria: Merck, Roche, Takeda Pharmaceuticals, Janssen, AbbVie; Research Funding: Janssen (Inst), Curis (Inst), Pharmacyclics (Inst), Roche (Inst), AstraZeneca (Inst), Genentech (Inst).

Keywords: employment leadership; janssen; leadership position; johnson

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.